Communicate

Cancellation of RRP Focus Session Originally Scheduled Sept. 20th: http://rrpwebsite.org/forum/index.cfm?page=topic&topicID=96

In the News

News about RRP

• Scientists develop new cancer-killing compound (ART at Univ. of WA.)
• RRP ISA/RRPF Joint Letter on Artemisinin
• FEMA trailers toxic, tests show
• Pulmonary RRP (Tarceva and Celebrex)
• Nventa completes evaluation of second cohort in HspE7 Phase 1 cervical dysplasia trial
• Artemisinin & Gardasil Success Story + Updates
• "Genetics of Papilloma-induced Voice Disturbance" Report

News about HPV

• Sanford Foundation Initiative
• Gardasil Considered No Longer "Worth It"
• Avesthagen partners with ShigaMediX to develop vaccines for cervical cancer
• Clueless on STDs, Throat Cancer, and Oral Sex
• HPV Today (winter 2008 newsletter)
• Tattooing improves response to DNA vaccine
• HPV causing more oral cancer in men
• Head and Neck Cancer HPV Involvement
• HPV Today (fall 2007 newsletter)
• Symposium on New HPV Prophylactic Vaccines
• AAV2
• Case report of a laryngeal squamous cell carcinoma treated with artesunate (artemisinin analogue)

News about RRP ISA

• Cancellation of Sept. 20, 2008 RRP Focus Session
• New RRP ISA Website